Cargando…
Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial
PURPOSE: The aim of this study is to evaluate the efficacy, feasibility and acceptability of a co-designed lifestyle-focused text message intervention (EMPOWER-SMS) for breast cancer survivors’ self-efficacy, quality of life (QOL), mental (anxiety, depression, stress) and physical (endocrine therapy...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034445/ https://www.ncbi.nlm.nih.gov/pubmed/35460441 http://dx.doi.org/10.1007/s11764-022-01209-9 |
_version_ | 1784693113430736896 |
---|---|
author | Singleton, Anna C. Raeside, Rebecca Partridge, Stephanie R. Hyun, Karice K. Tat-Ko, Justin Sum, Stephanie Che Mun Hayes, Molly Chow, Clara K. Thiagalingam, Aravinda Maka, Katherine Sherman, Kerry A. Elder, Elisabeth Redfern, Julie |
author_facet | Singleton, Anna C. Raeside, Rebecca Partridge, Stephanie R. Hyun, Karice K. Tat-Ko, Justin Sum, Stephanie Che Mun Hayes, Molly Chow, Clara K. Thiagalingam, Aravinda Maka, Katherine Sherman, Kerry A. Elder, Elisabeth Redfern, Julie |
author_sort | Singleton, Anna C. |
collection | PubMed |
description | PURPOSE: The aim of this study is to evaluate the efficacy, feasibility and acceptability of a co-designed lifestyle-focused text message intervention (EMPOWER-SMS) for breast cancer survivors’ self-efficacy, quality of life (QOL), mental (anxiety, depression, stress) and physical (endocrine therapy medication adherence, physical activity, BMI) health. METHODS: Single-blind randomised controlled trial (1:1) comparing EMPOWER-SMS to usual care at 6-months (intention-to-treat). Setting: public Breast Cancer Institute (Sydney, Australia). Eligibility criteria: adult (> 18 years) females, < 18-months post-active breast cancer treatment (stage I-III), owned a mobile phone, written informed consent. Primary outcome: Self-Efficacy for Managing Chronic Disease Scale at 6 months. Process data: message delivery analytics, cost, and post-intervention survey. RESULTS: Participants (N = 160; mean age ± SD 55.1 ± 11.1 years) were recruited 29th-March-2019 to 7th-May-2020 and randomised (n = 80 EMPOWER-SMS: n = 80 control). Baseline mean self-efficacy was high (I: 7.1 [95%CI 6.6, 7.5], C: 7.4 [7, 7.8]). Six-month follow-up: no significant differences between groups for self-efficacy (I: 7.6 [7.3, 7.9], C: 7.6 [7.3, 7.9], adjusted mean difference 0 (95%CI 0.4, 0.4), QOL, mental health, physical activity, or BMI. Significantly less EMPOWER-SMS participants missed ≥ 1 endocrine therapy medication doses compared to control (I: 3/42[7.1%], C: 8/47[17.0%], Adjusted RR 0.13 [95%CI 0.02, 0.91]). Text messages were delivered successfully (7925/8061, 98.3%), costing $13.62USD/participant. Participants strongly/agreed EMPOWER-SMS was easy-to-understand (64/64; 100%), useful (58/64; 90.6%), motivating for lifestyle change (43/64; 67.2%) and medication adherence (22/46; 47.8%). CONCLUSION: EMPOWER-SMS was feasible, inexpensive, acceptable for delivering health information to breast cancer survivors between medical appointments, with minor improvements in medication adherence. IMPLICATIONS FOR CANCER SURVIVORS: Text messages offer a feasible strategy for continuity-of-care between medical appointments. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11764-022-01209-9. |
format | Online Article Text |
id | pubmed-9034445 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-90344452022-04-25 Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial Singleton, Anna C. Raeside, Rebecca Partridge, Stephanie R. Hyun, Karice K. Tat-Ko, Justin Sum, Stephanie Che Mun Hayes, Molly Chow, Clara K. Thiagalingam, Aravinda Maka, Katherine Sherman, Kerry A. Elder, Elisabeth Redfern, Julie J Cancer Surviv Original Research PURPOSE: The aim of this study is to evaluate the efficacy, feasibility and acceptability of a co-designed lifestyle-focused text message intervention (EMPOWER-SMS) for breast cancer survivors’ self-efficacy, quality of life (QOL), mental (anxiety, depression, stress) and physical (endocrine therapy medication adherence, physical activity, BMI) health. METHODS: Single-blind randomised controlled trial (1:1) comparing EMPOWER-SMS to usual care at 6-months (intention-to-treat). Setting: public Breast Cancer Institute (Sydney, Australia). Eligibility criteria: adult (> 18 years) females, < 18-months post-active breast cancer treatment (stage I-III), owned a mobile phone, written informed consent. Primary outcome: Self-Efficacy for Managing Chronic Disease Scale at 6 months. Process data: message delivery analytics, cost, and post-intervention survey. RESULTS: Participants (N = 160; mean age ± SD 55.1 ± 11.1 years) were recruited 29th-March-2019 to 7th-May-2020 and randomised (n = 80 EMPOWER-SMS: n = 80 control). Baseline mean self-efficacy was high (I: 7.1 [95%CI 6.6, 7.5], C: 7.4 [7, 7.8]). Six-month follow-up: no significant differences between groups for self-efficacy (I: 7.6 [7.3, 7.9], C: 7.6 [7.3, 7.9], adjusted mean difference 0 (95%CI 0.4, 0.4), QOL, mental health, physical activity, or BMI. Significantly less EMPOWER-SMS participants missed ≥ 1 endocrine therapy medication doses compared to control (I: 3/42[7.1%], C: 8/47[17.0%], Adjusted RR 0.13 [95%CI 0.02, 0.91]). Text messages were delivered successfully (7925/8061, 98.3%), costing $13.62USD/participant. Participants strongly/agreed EMPOWER-SMS was easy-to-understand (64/64; 100%), useful (58/64; 90.6%), motivating for lifestyle change (43/64; 67.2%) and medication adherence (22/46; 47.8%). CONCLUSION: EMPOWER-SMS was feasible, inexpensive, acceptable for delivering health information to breast cancer survivors between medical appointments, with minor improvements in medication adherence. IMPLICATIONS FOR CANCER SURVIVORS: Text messages offer a feasible strategy for continuity-of-care between medical appointments. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11764-022-01209-9. Springer US 2022-04-23 2023 /pmc/articles/PMC9034445/ /pubmed/35460441 http://dx.doi.org/10.1007/s11764-022-01209-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Research Singleton, Anna C. Raeside, Rebecca Partridge, Stephanie R. Hyun, Karice K. Tat-Ko, Justin Sum, Stephanie Che Mun Hayes, Molly Chow, Clara K. Thiagalingam, Aravinda Maka, Katherine Sherman, Kerry A. Elder, Elisabeth Redfern, Julie Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial |
title | Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial |
title_full | Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial |
title_fullStr | Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial |
title_full_unstemmed | Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial |
title_short | Supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial |
title_sort | supporting women’s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the empower-sms randomised clinical trial |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034445/ https://www.ncbi.nlm.nih.gov/pubmed/35460441 http://dx.doi.org/10.1007/s11764-022-01209-9 |
work_keys_str_mv | AT singletonannac supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial AT raesiderebecca supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial AT partridgestephanier supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial AT hyunkaricek supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial AT tatkojustin supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial AT sumstephaniechemun supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial AT hayesmolly supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial AT chowclarak supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial AT thiagalingamaravinda supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial AT makakatherine supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial AT shermankerrya supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial AT elderelisabeth supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial AT redfernjulie supportingwomenshealthoutcomesafterbreastcancertreatmentcomparingatextmessageinterventiontousualcaretheempowersmsrandomisedclinicaltrial |